(Q53512333)

15 May 2018

title

Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. (English)

1 reference

15 May 2018

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

main subject

1 reference

2

1 reference

15 May 2018

Claudio Landoni

object named as

Claudio Landoni

3

0 references

author name string

Sandro Sironi

1

1 reference

15 May 2018

Stefania Galimberti

4

1 reference

15 May 2018

Mauro Signorelli

5

1 reference

15 May 2018

Valentino Bettinardi

6

1 reference

15 May 2018

Patrizia Perego

7

1 reference

15 May 2018

Costantino Mangioni

8

1 reference

15 May 2018

Cristina Messa

9

1 reference

15 May 2018

Ferruccio Fazio

10

1 reference

15 May 2018

publication date

16 November 2006

1 reference

15 May 2018

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

15 May 2018

volume

34

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

472-479

1 reference

15 May 2018

Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0251-Y

Clinical value of positron emission tomography with FDG for recurrent ovarian cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0251-Y

Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.

21 January 2018

1 reference

12 December 2020

Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.

1 reference

12 December 2020

Statistical methods for the estimation of sensitivity and specificity of site‐specific diagnostic tests

1 reference

12 December 2020

Unknown primary tumors: detection with dual-modality PET/CT--initial experience

1 reference

12 December 2020

Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer

1 reference

12 December 2020

The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies

1 reference

12 December 2020

18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis

1 reference

12 December 2020

Dynamic MR imaging of recurrent postoperative cervical cancer

1 reference

12 December 2020

18F-FDG PET in the management of endometrial cancer.

1 reference

12 December 2020

Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome

1 reference

12 December 2020

Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

1 reference

12 December 2020

Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

1 reference

12 December 2020

A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study

1 reference

12 December 2020

Posttherapy surveillance monitoring of cervical cancer by FDG-PET.

1 reference

12 December 2020

Clinical applications of PET in oncology

1 reference

12 December 2020

Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma

1 reference

12 December 2020

The clinical application of serum squamous cell carcinoma antigen level monitoring in invasive cervical carcinoma

1 reference

12 December 2020

The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.

1 reference

12 December 2020

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT.

1 reference

12 December 2020

Recurrence of endometrial carcinoma and the value of routine follow up.

1 reference

12 December 2020

Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.

1 reference

12 December 2020

Posttherapy surveillance of women with cervical cancer: an outcomes analysis

1 reference

12 December 2020

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology

1 reference

12 December 2020

Initial experience with oral contrast in PET/CT: phantom and clinical studies.

1 reference

12 December 2020

Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions

1 reference

12 December 2020

Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma

1 reference

12 December 2020

Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T

1 reference

12 December 2020

Evaluation of FDG PET in patients with cervical cancer

1 reference

12 December 2020

Computed tomography in endometrial carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Endometrial carcinoma

1 reference

12 December 2020

Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.

1 reference

12 December 2020

Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

1 reference

12 December 2020

A combined PET/CT scanner: the choices

1 reference

12 December 2020

Integrated PET/CT: current applications and future directions

1 reference

12 December 2020

Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

1 reference

12 December 2020

Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies

1 reference

12 December 2020

10.1007/S00259-006-0251-Y

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018